Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|July 2, 2021
Induction of EBV latent membrane protein-2A (LMP2A)-specific T cells and construction of individualized TCR-engineered T cells for EBV-associated malignanciesChaoting Zhang, Qin Tan, Shance Li, et al.
Neural Networks : the Official Journal of the International Neural Network Society|March 24, 2026
Improving anomaly detection with foundation-model synthesis and wavelet-domain attentionWensheng Wu, Zheming Lu, Ziqian Lu, et al.
The Journal of Pathology|May 13, 2016
T cell receptor β-chain repertoire analysis reveals intratumour heterogeneity of tumour-infiltrating lymphocytes in oesophageal squamous cell carcinomaZengchao Chen, Chaoting Zhang, Yaqi Pan, et al.
Scientific Reports|October 21, 2016
Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technologyYing Liu, Chaoting Zhang, Weijiao Gao, et al.
Cellular Immunology|August 3, 2025
Identification of Epstein-Barr virus nuclear antigen 1 (EBNA1)-specific T-cell receptors: implications for immunotherapy targeting EBV-associated malignanciesYing Liu, Yaqi Pan, Huirong Ding, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|March 17, 2018
Differential DNA methylation profiles of human B lymphocytes and Epstein-Barr virus-immortalized B lymphocytesChaoting Zhang, Rui Zhang, Zhiqiang Chen, et al.
Clinical & Translational Immunology|October 3, 2022
Autophagic flux restoration of senescent T cells improves antitumor activity of TCR-engineered T cellsChaoting Zhang, Yizhe Sun, Shance Li, et al.
Pharmacological Research|March 16, 2026
Overcoming stromal resistance in solid tumors with MMP2-engineered CAR-T cellsJiaxin Tu, Yuge Zhu, Xinyu Li, et al.
Journal for Immunotherapy of Cancer|August 30, 2019
Isolation of T cell receptor specifically reactive with autologous tumour cells from tumour-infiltrating lymphocytes and construction of T cell receptor engineered T cells for esophageal squamous cell carcinomaQin Tan, Chaoting Zhang, Wenjun Yang, et al.
Cancer Letters|April 30, 2022
Metabolic reprogramming by ex vivo glutamine inhibition endows CAR-T cells with less-differentiated phenotype and persistent antitumor activityLuyan Shen, Yefei Xiao, Chaoting Zhang, et al.
Pageof 6